<DOC>
	<DOCNO>NCT00189956</DOCNO>
	<brief_summary>The objective study find optimal dose smallpox candidate vaccine IMVAMUNE ( MVA-BN ) . For purpose study compare IMVAMUNE ( MVA-BN ) administer three different dose level .</brief_summary>
	<brief_title>Dose-finding Study Evaluate Immunogenicity Three Different Dose Levels IMVAMUNE ( MVA-BN ) Smallpox Vaccine .</brief_title>
	<detailed_description />
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male female subject , age 18 30 year Signed informed consent advise risk benefit study language able understand , prior performance study specific procedure . Free obvious health problem acceptable medical history screen evaluation physical examination . Subject childbearing potential following : A urine/serum ÃŸHCG pregnancy test give negative result , use adequate contraceptive precaution 30 day first vaccination . Known suspected history smallpox vaccination typical vaccinia scar . Positive test result MVA specific ELISA PRNT screen . Positive result HIV HCV antibody test screening . HbsAG positive screening . Pregnancy breastfeed . Uncontrolled serious infection i.e . respond antimicrobial therapy History serious medical condition , opinion investigator , would compromise safety subject . History autoimmune disease History malignancy . History chronic alcohol abuse and/or intravenous drug abuse . History allergic disease reaction likely exacerbate component vaccine . History anaphylaxis severe allergic reaction . Acute disease ( moderate severe illness without fever ) time enrolment . Any vaccination within period start 30 day prior administration vaccine end study conclusion . Chronic administration immunosuppressant immunemodifying drug . Administration plan administration immunoglobulin and/or blood product study period . Use investigational nonregistered drug vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>